Arian Emami Riedmaier
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems 3
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 2
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 7
- Pancreatic and Hepatic Oncology Research 1
-
- Pharmacological Effects and Toxicity Studies 4
-
- Statistical Methods in Clinical Trials 3
-
- Pesticide Residue Analysis and Safety 1
-
- Crystallization and Solubility Studies 1
- Co-authors
- Matthias SchwabAnne T. NiesElke SchaeffelerPascale FiselHoward BurtSibylle NeuhoffNeil ParrottXavier Pépin
- Journals
- Pharmacological Reviews (1 paper)Trends in Pharmacological Sciences (1 paper)Journal of Pharmaceutical Sciences (2 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Arian Emami Riedmaier
12 papers receiving 590 citations
Peers
Comparison fields: 5 of 74
- Pharmaceutical Science 106
- Pharmacology 152
- Oncology 287
- Pediatrics, Perinatology and Child Health 134
- Analytical Chemistry 34
Countries citing papers authored by Arian Emami Riedmaier
This map shows the geographic impact of Arian Emami Riedmaier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arian Emami Riedmaier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arian Emami Riedmaier more than expected).
Fields of papers citing papers by Arian Emami Riedmaier
This network shows the impact of papers produced by Arian Emami Riedmaier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arian Emami Riedmaier. The network helps show where Arian Emami Riedmaier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Arian Emami Riedmaier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 11 | |
| 2 | 2023 | 9 | |
| 3 | 2021 | 28 | |
| 4 | 2021 | 28 | |
| 5 | 2021 | 7 | |
| 6 | 2020 | 19 | |
| 7 | 2019 | 110 | |
| 8 | 2017 | 58 | |
| 9 | 2016 | 59 | |
| 10 | 2015 | 34 | |
| 11 | 2012 | 137 | |
| 12 | 2012 | 101 |
About Arian Emami Riedmaier
Arian Emami Riedmaier is a scholar working on Pharmaceutical Science, Transplantation and Statistics and Probability, having authored 12 papers that have together received 601 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), Pharmacological Effects and Toxicity Studies (4 papers), Drug Solubulity and Delivery Systems (3 papers), Statistical Methods in Clinical Trials (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), Pesticide Residue Analysis and Safety (1 paper) and Crystallization and Solubility Studies (1 paper). The work is most often cited by research in Pharmaceutical Science (106 citations), Pharmacology (152 citations) and Oncology (287 citations). Arian Emami Riedmaier has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Matthias Schwab, Anne T. Nies, Elke Schaeffeler, Pascale Fisel, Howard Burt, Sibylle Neuhoff, Neil Parrott, Xavier Pépin, Matthew D. Harwood and Katherine L. Gill. Their work appears in journals such as Pharmacological Reviews, Trends in Pharmacological Sciences and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.